167 related articles for article (PubMed ID: 1303649)
1. Screening for neuroblastoma in the north of England.
Parker L; Craft AW; Dale G; Bell S; Cole M; McGill AC; Seviour JA; Smith J
BMJ; 1992 Nov; 305(6864):1260-3. PubMed ID: 1303649
[TBL] [Abstract][Full Text] [Related]
2. False positive results in a neuroblastoma screening programme.
Bell S; Parker L; Craft AW; Dale G; McGill AC; Seviour J; Cole M; Smith J
Med Pediatr Oncol; 1994; 22(3):181-6. PubMed ID: 8272007
[TBL] [Abstract][Full Text] [Related]
3. Creatinine related reference ranges for urinary homovanillic acid and vanillylmandelic acid at 6 months of age.
Cole M; Parker L; Craft AW; Bell S; Dale G; McGill AC; Seviour JA; Smith J
Arch Dis Child; 1993 Mar; 68(3):376-8. PubMed ID: 8466241
[TBL] [Abstract][Full Text] [Related]
4. Screening for neuroblastoma in the northern region of England. Laboratory aspects.
Seviour JA; McGill AC; Craft AW; Parker L; Bell S; Cole M; Smith J; Hawkins E; Brown J; Dale GA
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):332-6. PubMed ID: 1456399
[TBL] [Abstract][Full Text] [Related]
5. A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations.
Mathieu P; Frappaz D; Chauvin F; Combaret V; Vercherat M; Brunat-Mentigny M; David L; Esteve J; Favrot M; Fouillat V; Greffe J; Lasset C; Renaud P; Philip T
Early Hum Dev; 1996 Sep; 46(1-2):177-96. PubMed ID: 9019414
[TBL] [Abstract][Full Text] [Related]
6. Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants.
Hanai J; Kawai T; Sato Y; Takasugi N; Nishi M; Takeda T
Clin Chem; 1987 Nov; 33(11):2043-6. PubMed ID: 3677377
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of screening for neuroblastoma in the north of England.
Craft AW; Parker L; Dale G; McGill AC; Seviour JA; Bell S; Cole M; Smith J
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):337-41. PubMed ID: 1456400
[TBL] [Abstract][Full Text] [Related]
8. Biochemical screening for neuroblastoma in infants: a feasibility study.
Craft AW; Dale G; McGill A; Seviour J; Spence EM
Med Pediatr Oncol; 1989; 17(5):373-8. PubMed ID: 2796853
[TBL] [Abstract][Full Text] [Related]
9. Thin-layer chromatography of urinary homovanillic acid and vanillylmandelic acid for large-scale neuroblastoma mass screening.
Auray-Blais C; Giguère R; Lemieux B
Med Pediatr Oncol; 1989; 17(5):364-7. PubMed ID: 2796851
[No Abstract] [Full Text] [Related]
10. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1986 Dec; 16(4):351-5. PubMed ID: 3795531
[TBL] [Abstract][Full Text] [Related]
11. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1987 Sep; 17(3):221-8. PubMed ID: 3669365
[TBL] [Abstract][Full Text] [Related]
12. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
Tuchman M; Lemieux B; Auray-Blais C; Robison LL; Giguere R; McCann MT; Woods WG
Pediatrics; 1990 Nov; 86(5):765-73. PubMed ID: 2152340
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study for neonatal neuroblastoma screening in the United States.
Tuchman M; Fisher EJ; Heisel MA; Woods WG
Med Pediatr Oncol; 1989; 17(4):258-64. PubMed ID: 2747596
[TBL] [Abstract][Full Text] [Related]
14. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
[TBL] [Abstract][Full Text] [Related]
15. Can mass screening for neuroblastoma detect patients with low vanillylmandelic acid and high homovanillic acid?
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Acta Paediatr Jpn; 1989 Dec; 31(6):742-4. PubMed ID: 2516402
[No Abstract] [Full Text] [Related]
16. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
17. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
[TBL] [Abstract][Full Text] [Related]
18. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
Sato Y; Hanai J; Takasugi N; Takeda T
Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
[TBL] [Abstract][Full Text] [Related]
19. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
Chauvin F; Mathieu P; Frappaz D; Lasset C; Favrot MC; Greffe J; Esteve J; Thiesse P; Combaret V; Chauvot P; Boschetti R; David L; Brunat-Mentigny M; Philip T
Med Pediatr Oncol; 1997 Feb; 28(2):81-91. PubMed ID: 8986143
[TBL] [Abstract][Full Text] [Related]
20. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
Tuchman M; Ramnaraine ML; Woods WG; Krivit W
Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
